Emerging Global Leader Award (K43 Independent Clinical Trial Required)

The summary for the Emerging Global Leader Award (K43 Independent Clinical Trial Required) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Emerging Global Leader Award (K43 Independent Clinical Trial Required): This is a reissue of the Emerging Global Leader Program (K43) to align with the clinical trials policy.

Federal Grant Title:	Emerging Global Leader Award (K43 Independent Clinical Trial Required)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Education, Environment, Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-24-295
Type of Funding:	Grant
CFDA Numbers:	93.113, 93.172, 93.173, 93.233, 93.242, 93.279, 93.313, 93.398, 93.837, 93.838, 93.839, 93.840, 93.853, 93.866, 93.989
CFDA Descriptions:	Information not provided
Current Application Deadline:	December 3rd, 2026
Original Application Deadline:	December 3rd, 2026
Posted Date:	October 15th, 2024
Creation Date:	October 15th, 2024
Archive Date:	January 8th, 2027
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	October 15th, 2024

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); Applications for the K43 award must be submitted by academic education or research institutions in LMICs (as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups; low-income, lower-middle-income, and upper-middle-income countries are included). FIC's Country Eligibility Notice (NOT-TW-12-011 Notice of Change in Country Eligibility for Fogarty International Training Grants ) applies to this NOFO and states that for competing and re-competing research training grant applications (including the K43 mechanism), with the exception of Sub-Saharan African countries, FIC will no longer accept applications from, or applications that involve training of scientists from upper-middle-income countries that are also members of the G20 major economies (http://www.g20.org/en/members). For additional information see FIC's Country Eligibility page at https://www.fic.nih.gov/Grants/Pages/country-eligibility.aspx. Only non-domestic (non-U.S.) Entities (Foreign Institutions) in Low- or Middle-Income Countries are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Link to Full Grant Announcement: https://grants.nih.gov/grants/guide/pa-files/PAR-24-295.html
Grant Announcement Contact: NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (R...; • NIH Research Program Projects (Parent P01 Clinical Trial Optional); • Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional); • Institutional Mentored Career Development Award (Parent K12) (Clinical Trials Not Allowed); • Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed); • Outstanding New Environmental Scientist Award (ONES); • Environmental Health Sciences Core Center Grants; • Leiomyomata Uteri: Basic Science and Translational Research
More Grants from the National Institutes of Health: • Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinic...; • Immune Tolerance Network (UM1 Clinical Trial Required); • Coordinating Center for National Resource Network for the Study of Human Auditory and Vest...; • National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Cl...; • Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Interven...